FI942248A0 - N-trityyliasparagiinihapon johdannaiset fosfonaatti-NMDA-antagonistien valmistamiseksi - Google Patents

N-trityyliasparagiinihapon johdannaiset fosfonaatti-NMDA-antagonistien valmistamiseksi

Info

Publication number
FI942248A0
FI942248A0 FI942248A FI942248A FI942248A0 FI 942248 A0 FI942248 A0 FI 942248A0 FI 942248 A FI942248 A FI 942248A FI 942248 A FI942248 A FI 942248A FI 942248 A0 FI942248 A0 FI 942248A0
Authority
FI
Finland
Prior art keywords
preparation
tritylaspartic
acid derivatives
nmda antagonists
phosphonate
Prior art date
Application number
FI942248A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI942248A (fi
Inventor
Jeffrey P Whitten
Duane E Rudisill
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI942248A0 publication Critical patent/FI942248A0/fi
Publication of FI942248A publication Critical patent/FI942248A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI942248A 1991-11-15 1994-05-13 N-trityyliasparagiinihapon johdannaiset fosfonaatti-NMDA-antagonistien valmistamiseksi FI942248A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79283491A 1991-11-15 1991-11-15
PCT/US1992/008739 WO1993010075A1 (en) 1991-11-15 1992-10-13 N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists

Publications (2)

Publication Number Publication Date
FI942248A0 true FI942248A0 (fi) 1994-05-13
FI942248A FI942248A (fi) 1994-05-13

Family

ID=25158215

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942248A FI942248A (fi) 1991-11-15 1994-05-13 N-trityyliasparagiinihapon johdannaiset fosfonaatti-NMDA-antagonistien valmistamiseksi

Country Status (16)

Country Link
EP (1) EP0613459B1 (de)
JP (1) JP3168563B2 (de)
KR (1) KR100241480B1 (de)
AT (1) ATE134989T1 (de)
AU (1) AU667845B2 (de)
CA (1) CA2121835A1 (de)
DE (1) DE69208888T2 (de)
DK (1) DK0613459T3 (de)
ES (1) ES2087555T3 (de)
FI (1) FI942248A (de)
GR (1) GR3019587T3 (de)
HU (1) HU214055B (de)
IL (1) IL103710A (de)
MX (1) MX9206448A (de)
NO (1) NO305314B1 (de)
WO (1) WO1993010075A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2025326C (en) * 1989-09-19 2001-04-24 Jeffrey P. Whitten Nmda antagonists

Also Published As

Publication number Publication date
NO305314B1 (no) 1999-05-10
KR100241480B1 (ko) 2000-03-02
EP0613459B1 (de) 1996-03-06
HU214055B (en) 1997-12-29
IL103710A0 (en) 1993-04-04
ES2087555T3 (es) 1996-07-16
HU9401469D0 (en) 1994-08-29
IL103710A (en) 1998-02-08
JPH07501523A (ja) 1995-02-16
EP0613459A1 (de) 1994-09-07
CA2121835A1 (en) 1993-05-27
NO941820L (no) 1994-05-13
NO941820D0 (no) 1994-05-13
JP3168563B2 (ja) 2001-05-21
DE69208888D1 (de) 1996-04-11
FI942248A (fi) 1994-05-13
ATE134989T1 (de) 1996-03-15
HUT70551A (en) 1995-10-30
AU2864292A (en) 1993-06-15
DE69208888T2 (de) 1996-08-01
WO1993010075A1 (en) 1993-05-27
DK0613459T3 (da) 1996-04-01
MX9206448A (es) 1993-05-01
GR3019587T3 (en) 1996-07-31
AU667845B2 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
ES2078257T3 (es) Antagonistas de aminoacidos excitantes.
FI904851A0 (fi) Radiomaerkta antikoagulantpeptider.
ES2088011T3 (es) Antagonistas de aminoacidos excitadores.
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
FI924642A (fi) Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
FI972065A (fi) Menetelmä N-fosfonometyyliglysiinin valmistamiseksi
DE69104220D1 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
DE69230224D1 (de) Potenzierung von nmda-antagonisten
DE68916850T2 (de) Antikoagulierende Peptid-Alkohole.
FI942248A0 (fi) N-trityyliasparagiinihapon johdannaiset fosfonaatti-NMDA-antagonistien valmistamiseksi
DE59201146D1 (de) Verfahren zur Herstellung von Methylchlorsilanen.
GR1001566B (el) Μέ?οδος παρασκευής νέων παραγώγων βενζοφουρανυλιμιδαζόλης.
DE69225254D1 (de) Verfahren zur Herstellung von diarylphosphino Pyridinen
GR1001309B (el) Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης.
FI97388B (fi) Menetelmä heterosyklisten NMDA-antagonistien valmistamiseksi
ES2032209T3 (es) Derivados de proteinas que contienen hierro en forma altamente biodisponible, su preparacion y composiciones farmaceuticas que los contienen.
DE69007362D1 (de) Verfahren zur Herstellung von staubfreiem Natriumdithionit.
ITMI912138A0 (it) Procedimento per la preparazione di fosfatidi
ITMI910434A0 (it) Procedimento migliorativo per la sintesi di n-fosfonometilglicina
MX9204659A (es) Nuevas 3-(tetrazolil substituido)-oxo-4h-pirido-(1,2-a)-pirimidinas, sales de los mismos, las composiciones farmaceuticas que contienen a los mismos y procedimientos para prepararlas
GR1001241B (el) Μεθοδος αλκυλιωσεως.